Barron's Medical Journal : J.P. Morgan Healthcare Conference The Best From Around The Globe In Pharmaceutical Life Science & Medicine
Barron’s Medical Journal attending the
J.P. Morgan Healthcare Conference In San Francisco at The Westin St. Francis Hotel | San Francisco, California. Jamie Dimon CEO JPMorgan Chase & Co. assembled the best and brightest Life Science at
The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth
companies, innovative technology creators, and members of the investment community.
9,000+
Total Attendees
450+
Private and Public Companies
History
What is today known as the annual J.P. Morgan Healthcare Conference began in 1983 and was hosted by Hambrecht & Quist (H&Q).
H&Q was acquired by Chase in 2000 and a year later Chase was acquired by J.P. Morgan. 
At its infancy, the conference featured just 20 companies, had about 200 attendees and focused on the biotech industry.
H&Q was acquired by Chase in 2000 and a year later Chase was acquired by J.P. Morgan. At its infancy, the conference featured just 20 companies, had about 200 attendees and focused on the biotech industry.
Healthcare remains a key issue for voters ahead of the 2020 elections, with drug pricing reform,
patient affordability and the changing role of the consumer major themes for both the U.S. pharmaceutical industry and the 2020 presidential candidates. J.P. Morgan Research explores the outlook for the industry in 2020 ahead of the election and beyond.
patient affordability and the changing role of the consumer major themes for both the U.S. pharmaceutical industry and the 2020 presidential candidates. J.P. Morgan Research explores the outlook for the industry in 2020 ahead of the election and beyond.
Today, while it is still at the Westin St. Francis in San Francisco, the annual J.P. Morgan Healthcare Conference brings thousands of investors from around the world together. The hundreds of companies presenting run the gamut, from start-ups to those with more than $300 billion in market cap, and encompass the entire global healthcare landscape, including pharmaceutical firms, healthcare service providers, profit and not-for-profits, and medical device companies.
“JPM Week” brings with it dozens of company announcements and serves as the origin point for even more future deals. Case in point: On Monday morning, Patrick Soon-Shiong – a physician-turned-biotech executive who also happens to be the richest man in Los Angeles and the new owner of the
Los Angeles Times – announced the latest investment in his biopharma federation. The privately-held cancer immunotherapy firm NantCell, which Soon-Shiong founded, has secured an additional $30 million in funding from Celgene, bringing the biotech giant’s investment in NantCell to $105 million at a $4 billion valuation. Readers are likely aware that, just last week, U.S. pharma mainstay and cancer drug leader Bristol-Myers Squibb announced a mega-blockbuster deal to acquire Celgene.
Los Angeles Times – announced the latest investment in his biopharma federation. The privately-held cancer immunotherapy firm NantCell, which Soon-Shiong founded, has secured an additional $30 million in funding from Celgene, bringing the biotech giant’s investment in NantCell to $105 million at a $4 billion valuation. Readers are likely aware that, just last week, U.S. pharma mainstay and cancer drug leader Bristol-Myers Squibb announced a mega-blockbuster deal to acquire Celgene.
Soon-Shiong describes NantCell as part of a three-legged stool of sorts alongside his other cancer-focused companies, NantHealth and NantKwest. The ambitious goal of this triumverate? To develop a cancer vaccine that could theoretically combat multiple kinds of tumors using the body’s immune system without the need for toxic chemotherapy.
The explosion of knowledge in the genomics world. We have a guest post up on Fortune co-written by Bryan Roberts, one of the investing gurus over at Venrock, and John Stuelpnagel,
a co-founder of Illumina and Ariosa Diagnostics, as well as the chairman of biotech Inscripta (note: Venrock is an investor in the latter firm). Bryan and John delve into the explosion of knowledge that’s driving change in the genomic sequencing space—a “revolution of observation,”
as they put it. Read the whole thing here.
a co-founder of Illumina and Ariosa Diagnostics, as well as the chairman of biotech Inscripta (note: Venrock is an investor in the latter firm). Bryan and John delve into the explosion of knowledge that’s driving change in the genomic sequencing space—a “revolution of observation,”as they put it. Read the whole thing here.
San Francisco. The big biopharma bash. The life of the life sciences scene. The Woodstock of would-be drug developers.
The 38th annual JP Morgan Healthcare Conference—a confab that attracts thousands of investors, biopharma executives, academics, and a fair number of us ink-stained wretches eager to cover the craziness each year.
WHAT A GREAT MIRACLE THAT I HAVE EVER SEE IN MY LIFE. My names are Clara David I’m a citizen of USA, My younger sister was sicking of breast cancer and her name is Sandra David I and my family have taking her to all kind of hospital in USA still yet no good result. I decided to make search for cancer cure so that was how I find a lady called peter Lizzy she was testifying to the world about the goodness of a herbal man who has the roots and herbs to cure all kind of disease and the herbal man email was there. So I decided to contact the herbal man @herbalist_sakura for my younger sister help to cure her breast cancer. I contacted him and told him my problem he told me that I should not worry that my sister cancer will be cure, he told me that there is a medicine that he is going to give me that I will cook it and give it to my sister to drink for one week, so I ask how can I receive the cure that I am in USA, he told me That I will pay for the delivery service. The courier service can transport it to me so he told me the amount I will pay, so my dad paid for the delivery fee. two days later I receive the cure from the courier service so I used it as the herbal man instructed me to, before the week complete my sister cancer was healed and it was like a dream to me not knowing that it was physical I and my family were very happy about the miracle of Doctor so my dad wanted to pay him 5 million us dollars the herbal man did not accept the offer from my dad, but I don't know why he didn't accept the offer, he only say that I should tell the world about him and his miracle he perform so am now here to tell the world about him if you or your relative is having any kind of disease that you can't get from the hospital please contact dr.sakuraspellalter@gmail.com or whats app him +2348110114739 you can follow him up on Instagram @herbalist_sakura for the cure, he will help you out with the problem. And if you need more information about the doctor you can mail me davidclara223@gmail.com
ReplyDelete